180 Life Sciences Files 8-K on Shareholder Nominations
Ticker: FRMM · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-nominations, board-of-directors, corporate-governance
Related Tickers: ATNF
TL;DR
180 Life Sciences filed an 8-K for shareholder nominations & other events.
AI Summary
On June 25, 2025, 180 Life Sciences Corp. filed an 8-K report detailing shareholder nominations for its board of directors and other events. The company, previously known as KBL Merger Corp. IV, is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates potential changes in the company's board composition, which could influence strategic direction and governance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of shareholder nominations and other events, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former company name
- June 25, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for 180 Life Sciences Corp.?
The primary purpose of this 8-K filing is to report shareholder nominations for the board of directors and other events.
When was this 8-K report filed?
This 8-K report was filed on June 25, 2025.
What was 180 Life Sciences Corp. formerly known as?
180 Life Sciences Corp. was formerly known as KBL Merger Corp. IV.
In which state is 180 Life Sciences Corp. incorporated?
180 Life Sciences Corp. is incorporated in Delaware.
What is the Standard Industrial Classification (SIC) code for 180 Life Sciences Corp.?
The SIC code for 180 Life Sciences Corp. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding 180 Life Sciences Corp. (FRMM).